| | | | | | | |
 | MERCK KGAA | 0.00% | 6.78% | -24.36% | 1.63% | 84.15% | 75 996 |
 | KYOWA KIRIN CO. LTD. | 2.09% | 1.96% | 1.44% | -20.10% | 67.72% | 12 328 |
 | SK BIOPHARMACEUTICALS CO., LTD. | -2.69% | 1.34% | -21.91% | -42.28% | --.--% | 4 550 |
 | BETTA PHARMACEUTICALS CO., LTD. | 1.51% | -2.88% | -26.03% | -41.12% | 39.66% | 3 657 |
| YUHAN CORPORATION | -1.04% | 1.96% | -8.05% | -6.90% | 36.57% | 2 973 |
 | DOTTIKON ES HOLDING AG | 3.90% | -2.15% | -24.47% | -18.70% | 294.44% | 2 909 |
| ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. | 10.00% | 21.39% | 77.64% | 86.45% | 720.09% | 2 768 |
| SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD. | 0.55% | 9.50% | 288.93% | --.--% | --.--% | 2 753 |
 | INDIVIOR PLC | 1.31% | -1.48% | 20.54% | 93.87% | 589.98% | 2 542 |
| SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | 1.90% | 1.65% | -0.31% | 1.43% | 45.88% | 1 660 |
 | SUPERNUS PHARMACEUTICALS, INC. | 0.36% | 7.02% | 4.97% | 5.26% | -3.65% | 1 629 |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | 0.27% | 3.26% | -25.71% | -37.10% | --.--% | 1 593 |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | -1.77% | -4.44% | -8.78% | -1.87% | 3.16% | 1 448 |
| SHENYANG XINGQI PHARMACEUTICAL CO.,LTD | -12.08% | -28.71% | -20.10% | -8.00% | 71.32% | 1 435 |
 | SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. | 0.30% | -2.37% | -14.29% | -36.17% | -43.59% | 1 197 |
| | | | | | | |
| | Moyenne | 0.31% | 0.86% | 14.63% | -1.69% | 158.81% | |
| | Moyenne pondérée par Capi. | 0.37% | 4.90% | -9.65% | -1.45% | 108.17% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
